Literature DB >> 7828164

Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene.

Y Iwanuma1, K Kato, H Yagita, K Okumura.   

Abstract

To study the antitumor effect of local production of interleukin-2 (IL-2) from tumor cells, the poorly immunogenic murine colon cancer cells, colon26, was transfected with murine IL-2 cDNA in a bovine papilloma virus vector. IL-2 gene transfectants (mIL2 + colon26) did not alter their growth rate compared with parental colon26 cells in vitro, but reduced their tumorigenicity in vivo. Immunization with mIL2 + colon26 cells could induce protective immunity against parental colon26 cells. Following intravenous challenges, the colonies of lung metastasis were also inhibited. Moreover, inoculation of mIL2 + colon26 cells slowed the growth of challenged renal cell carcinoma cells, RenCa. Intraperitoneal inoculation of IL-2 gene transfectants generated a large number of peritoneal exudate cells and these cells had a highly cytolytic activity against colon26 and YAC-1. These results suggest that inoculation with IL-2 transfected tumor cells can stimulate not only cytotoxic T lymphocytes but also natural killer cells, and that these cells will act as antitumor effector cells in host animals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7828164     DOI: 10.1007/bf01517231

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  35 in total

Review 1.  Structure and function of perforin.

Authors:  E R Podack; K J Olsen; D M Lowrey; M Lichtenheld
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

2.  The biology and clinical applications of interleukin 2.

Authors:  R C Rees; R H Wiltrout
Journal:  Immunol Today       Date:  1990-02

3.  Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity.

Authors:  D S Heo; J G Park; K Hata; R Day; R B Herberman; T L Whiteside
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

4.  Regional differences in the incidence and growth of mouse tumors following intradermal or subcutaneous inoculation.

Authors:  R Auerbach; L W Morrissey; Y A Sidky
Journal:  Cancer Res       Date:  1978-06       Impact factor: 12.701

5.  Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.

Authors:  A Porgador; R Bannerji; Y Watanabe; M Feldman; E Gilboa; L Eisenbach
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

6.  Early appearance and activation of natural killer cells in tumor-infiltrating lymphoid cells during tumor development.

Authors:  S Kurosawa; G Matsuzaki; M Harada; T Ando; K Nomoto
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

7.  Growth inhibition of an MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations. Preliminary report.

Authors:  J Bubeník; P Perlmann; M Indrová; J Símová; T Jandlová; J Neuwirt
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties.

Authors:  M Nagarkatti; S R Clary; P S Nagarkatti
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

9.  Establishment of mouse colonic carcinoma cell lines with different metastatic properties.

Authors:  M G Brattain; J Strobel-Stevens; D Fine; M Webb; A M Sarrif
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

10.  Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

Authors:  S A Rosenberg; J J Mulé; P J Spiess; C M Reichert; S L Schwarz
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  5 in total

1.  Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.

Authors:  H M Karpoff; M D'Angelica; S Blair; M D Brownlee; H Federoff; Y Fong
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.

Authors:  M D'Angelica; C Tung; P Allen; M Halterman; K Delman; T Delohery; D Klimstra; M Brownlee; H Federoff; Y Fong
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

3.  Effects of immunization with tumor cells double transfected with interleukin-2 (IL-2) and interleukin-12 (IL-12) genes on artificial metastasis of colon26 cells in BALB/c mice.

Authors:  T Takada; K Kato; H Yagita; H Hamada; K Okumura
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

4.  Immune reactions induced by interleukin-2 transfected colorectal cancer cells in vitro: predominant induction of lymphokine-activated killer cells.

Authors:  M Lindauer; H K Schackert; J Gebert; W Rudy; A Habicht; M Siebels; S C Meuer; U Moebius
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

5.  A human natural antibody to adenocarcinoma that inhibits tumour cell migration.

Authors:  K Koda; N Nakajima; N Saito; J Yasutomi; M E McKnight; M C Glassy
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.